Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2010

Jan 8, 2010

32566_dirs_2010-01-08_1f47e3af-ddf3-4565-be72-092949c55694.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-01-07

Reporting Person: WILSON LINDA S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-01-07 Common Stock S 2500 $26.9043 Disposed 2500 Direct
2010-01-07 Common Stock M 9000 $18.13 Acquired 11500 Direct
2010-01-07 Common Stock S 9000 $26.9043 Disposed 2500 Direct
2010-01-07 Common Stock M 9000 $6.32 Acquired 11500 Direct
2010-01-07 Common Stock S 9000 $26.9043 Disposed 2500 Direct
2010-01-07 Common Stock M 10000 $6.9 Acquired 12500 Direct
2010-01-07 Common Stock S 10000 $26.9043 Disposed 2500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-01-07 Non-Qualified Stock Option (right to buy) $6.32 M 9000 Disposed 2012-11-13 Common Stock (9000) Direct
2010-01-07 Non-Qualified Stock Option (right to buy) $6.9 M 10000 Disposed 2014-11-11 Common Stock (10000) Direct
2010-01-07 Non-Qualified Stock Option (right to buy) $18.13 M 9000 Disposed 2011-11-08 Common Stock (9000) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: One third vests annually beginning on the 1st anniversary of the option date.